CN109157546B - Compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei boone and application thereof - Google Patents

Compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei boone and application thereof Download PDF

Info

Publication number
CN109157546B
CN109157546B CN201810844204.1A CN201810844204A CN109157546B CN 109157546 B CN109157546 B CN 109157546B CN 201810844204 A CN201810844204 A CN 201810844204A CN 109157546 B CN109157546 B CN 109157546B
Authority
CN
China
Prior art keywords
microecological preparation
penaeus vannamei
preventing
providencia
compound microecological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201810844204.1A
Other languages
Chinese (zh)
Other versions
CN109157546A (en
Inventor
沈辉
甄晓然
万夕和
蒋葛
乔毅
王李宝
史文军
黎慧
范贤平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIANGSU MARINE FISHERIES RESEARCH INSTITUTE
Original Assignee
JIANGSU MARINE FISHERIES RESEARCH INSTITUTE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGSU MARINE FISHERIES RESEARCH INSTITUTE filed Critical JIANGSU MARINE FISHERIES RESEARCH INSTITUTE
Priority to CN201810844204.1A priority Critical patent/CN109157546B/en
Publication of CN109157546A publication Critical patent/CN109157546A/en
Application granted granted Critical
Publication of CN109157546B publication Critical patent/CN109157546B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention relates to a compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome (AHPNS) of penaeus vannamei boone and application thereof, wherein the compound microecological preparation comprises providencia and enterobacter. The compound microecological preparation is added into feed for feeding. The composite microecological preparation has a strong effect of inhibiting vibrio parahaemolyticus, has a remarkable application effect, is one of important ways for realizing green culture of penaeus vannamei boone, and has a good application prospect.

Description

Compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei boone and application thereof
Technical Field
The invention belongs to the field of disease prevention and control of aquatic products, and particularly relates to a compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei boone and application thereof.
Background
The acute hepatopancreas necrosis syndrome (AHPNS) of the penaeus vannamei is a disease which is mainly characterized in that the hepatopancreas of the penaeus vannamei is necrotic so as to cause sudden death of the penaeus vannamei, and is one of the most serious diseases affecting the culture of the penaeus vannamei in recent years. The Early stage of the disease mainly occurs in the seedling stage of prawns and is called Early Mortality Syndrome (EMS). It has been found that some Vibrio bacteria carrying a specific pathogenic gene are causative agents of the disease, and among them, Vibrio parahaemolyticus is mainly used. Tran et al isolated 1 Vibrio harveyi (Vibrio harveyi) from shrimp ponds with Vietnam AHPNS morbidity, and the mortality rate of the shrimps after soaking infection reached 100%. Joshi et al isolated several strains of Vibrio parahaemolyticus from Thailand shrimp, and infected the shrimp intramuscularly, wherein one group died 100% within 24h, and the strain detection was AHPNS positive. Liu isolated 1 strain of Vibrio owens in the sea AHPNS pathogenic shrimp pond, and the strain was considered as the AHPNS pathogenic strain. Xuan et al suggested that 1 strain of Vibrio campylobacter isolated from shrimp could lead to the development of AHPNS.
PirvpThe binary toxin coded by AB gene is the main virulence factor of pathogenic vibrio, the produced binary toxin has a structure similar to the parasporal crystal structure produced by bacillus thuringiensis, the virulence effect is similar to the virulence effect of bacillus thuringiensis Cry protein, and the binary toxin is inserted into the cell membrane of a host to form a die-through hole, so that the osmotic pressure inside and outside the cell is changed, and the target cell is damaged or even killed.
Some researchers begin to pay attention to the research and development of the microecological preparation, but the microecological preparation specially aiming at the acute hepatopancreas necrosis syndrome of the penaeus vannamei has not been published in any documents at present.
Disclosure of Invention
The invention aims to solve the technical problem of providing a compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei and application thereof, and overcomes the defect that no microecological preparation specially aiming at the acute hepatopancreas necrosis syndrome of penaeus vannamei exists in the existing product.
The invention provides a compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei, which comprises Providencia sp and Enterobacter sp; wherein the preservation number of providencia is CGMCC No.15415, and the preservation number of enterobacter is CGMCC No. 15416.
Providencia sp (Providencia sp.) used in the present invention, the name of the depository: CGMCC (China general microbiological culture Collection center) general microbiological culture Collection center, the preservation address is as follows: the microbial research institute of China academy of sciences No. 3, Xilu No.1, Beijing, Chaoyang, has a preservation number of CGMCC NO.15415 and a preservation date of 2018, 3 months and 6 days. The proposed classification is named: providencia (Providencia sp.).
Enterobacter (Enterobacter sp.) used in the present invention, the name of the depository unit: CGMCC (China general microbiological culture Collection center) general microbiological culture Collection center, the preservation address is as follows: the microbial research institute of China academy of sciences No. 3, Xilu No.1, Beijing, Chaoyang, has a preservation number of CGMCC NO.15416 and a preservation date of 2018, 3 months and 6 days. The proposed classification is named: enterobacter (Enterobacter sp.).
The providencia and the enterobacteria are respectively cultured until the concentration is 1.0 multiplied by 108CFU/mL and mixing for later use.
The formula of the adopted culture medium is as follows: 5g of peptone, 1g of yeast extract, 0.01g of ferric phosphate, 3g of sodium acetate, 1g of dipotassium phosphate, 1000mL of old seawater and 7.6-7.8 of pH value.
The preparation ratio of the providencia and the enterobacter after liquid fermentation is 1: 0.5-2.
The providencia and the enterobacter account for 2-3% of the composite microecological preparation.
The invention also provides application of the compound microecological preparation for preventing and controlling the acute hepatopancreas necrosis syndrome of the penaeus vannamei, and the compound microecological preparation is added into feed for feeding. Can not be mixed with antibiotics for use, and the dosage is as follows: and adding 20-40 ml of the compound microecologics into each kilogram of feed, and feeding for 3-5 days.
The invention is mainly used for preventing and controlling the acute hepatopancreatic necrosis syndrome of the penaeus vannamei boone, inhibiting the growth of the vibrio necrotizing to the acute hepatopancreatic necrosis and reducing the high death rate caused by the acute hepatopancreatic necrosis syndrome.
The providencia CGMCC No.15415 has the ability of synthesizing or semi-synthesizing lactam antibiotic active substances, can produce lipopeptide antibiotic substances, and can strongly inhibit pathogenic bacteria of penaeus vannamei.
The enterobacter CGMCC No.15416 can regulate intestinal flora balance, produce bacteriocin and lactic acid, inhibit pathogenic bacteria growth, and improve immunity and disease resistance of Penaeus vannamei Boone.
The inhibition performance of the pathogenic vibrio parahaemolyticus causing acute hepatopancreas necrosis of the penaeus vannamei can be further enhanced by combining the two according to the proportion of the invention, and in addition, the combination of the two can inhibit the pathogenic vibrio parahaemolyticus causing acute hepatopancreas necrosis of the penaeus vannamei within the range of Jiangsu province in 10 bacterial strains. However, the existing combination of bacillus subtilis and lactic acid bacteria in the market can only inhibit conventional vibrio parahaemolyticus to a certain extent, but cannot inhibit the pathogenic parahaemolyticus arc of acute hepatopancreas necrosis of penaeus vannamei of multiple bacterial strain types. The combination of the two strains of bacteria has definite specificity to the pathogenic vibrio parahaemolyticus of acute hepatopancreatic necrosis of 10 strains of penaeus vannamei in Jiangsu province.
Advantageous effects
The composite microecological preparation has a strong effect of inhibiting vibrio parahaemolyticus, has a remarkable application effect, is one of important ways for realizing green culture of penaeus vannamei boone, and has a good application prospect.
Detailed Description
The invention will be further illustrated with reference to the following specific examples. It should be understood that these examples are for illustrative purposes only and are not intended to limit the scope of the present invention. Further, it should be understood that various changes or modifications of the present invention may be made by those skilled in the art after reading the teaching of the present invention, and such equivalents may fall within the scope of the present invention as defined in the appended claims.
Example 1
This example provides a complex probiotic comprising Providencia sp and Enterobacter sp; wherein the preservation number of providencia is CGMCC No.15415, and the preservation number of enterobacter is CGMCC No. 15416. The two kinds of bacteria are respectively prepared according to the proportion of 1:1 after liquid fermentation. The two kinds of bacteria are cultured in advance to the concentration of 1.0X 108CFU/mL and mixing for later use. Wherein, the formula of the culture medium is as follows: 5g of peptone, 1g of yeast extract, 0.01g of ferric phosphate, 3g of sodium acetate, 1g of dipotassium phosphate, 1000mL of old seawater and 7.6-7.8 of pH value.
The use method of the composite microecological preparation comprises the following steps:
adding the culture mixed solution of providencia and enterobacter into the granulated feed for the penaeus vannamei, mixing the feed in a ratio of 1:50, feeding the mixed feed to the penaeus vannamei, and observing the eating condition of a bait table. Feeding for the first time every day on the day of 8: 00-9: 00 in the morning, feeding once every day for 2 hours, and feeding for 7 days.
The effect experiment of the composite microecological preparation is as follows:
test for inhibiting acute hepatopancreatic necrosis lethal vibrio
The method comprises the steps of selecting a prawn culture greenhouse with 9 prawn seedlings in a certain region of Jiangsu and consistent in growth state, infecting and outbreak of acute hepatopancreatic necrosis syndrome (about 0.7 mu/greenhouse), randomly dividing the prawn culture greenhouse into 3 groups, feeding the prawn culture greenhouse according to a common mode of farmers according to a control group (no addition of any microecological preparation), adding bacillus subtilis and lactic acid bacteria into feeds of the control group, adding a providencia and enterobacter composite microecological preparation into feeds of the test group, taking diseased prawn samples in ponds (each pond takes prawn samples at 3 different positions, takes hepatopancreatic organs in the prawn samples, mixing the prawn samples uniformly) on days 0, 1, 3, 5 and 7, qualitatively analyzing acute hepatopancreatic necrosis and lethal vibrio in hepatopancreatic tissue by adopting a molecular biological method, and observing the death condition of the prawns.
TABLE 1 changes in the number of Vibrio in Water
Figure BDA0001746274900000031
Note: different letters indicate significant difference (P <0.05), same letters indicate insignificant difference (P >0.05)
As can be seen from Table 1, in the control group without any probiotics, the acute hepatopancreatic necrosis syndrome pathogen exists in the shrimp body all the time, and the number of dead individuals is remarkably increased until all the shrimps die at day 5. In the control group, bacillus subtilis and lactic acid bacteria are used as a composite microecological preparation, the acute hepatopancreatic necrosis comprehensive disease pathogen in the shrimp bodies exists all the time, the number of dead individuals is remarkably increased, all the shrimps die in the 5 th day, and the control group has no remarkable difference with the control group. After 3 days of feeding the compound microecologics, the detection of the acute hepatopancreatic necrosis comprehensive disease pathogen is weak positive, and is negative after 5 days, dead individuals are remarkably reduced from 3 days later, and no dead individual is found at 7 days, so that the difference is remarkable compared with that before the use (P is less than 0.05). It can be seen that the use effect of the present example is significantly better than that of the first and second control groups.
Second, inhibition experiment of pathogenic vibrio plate
3 strains of acute hepatopancreatic necrosis syndrome lethal vibrio are selected in the test, and antagonism experiments are set by vibrio phagicus, bacillus, lactobacillus and the composite bacterium fermentation liquid. The test group is divided into four groups randomly, the first control group is bacteriophage, the second control group is bacillus, the third control group is lactic acid bacteria, and the test group is the composite bacteria. 3 pathogenic bacteria are separated and purified from the pathogenic shrimps in Jiangsu province, and the pathogenic bacteria contain acute hepatopancreatic necrosis syndrome virulence genes pirA and pirB which are numbered HYS-AHPND-1, HYS-AHPND-2 and HYS-AHPND-3 through molecular biological identification, and the concentration of the three pathogenic bacteria is 106CFU/ml is coated on an LB flat plate, four kinds of microorganism fermentation liquor (vibrio phagostii, bacillus, lactobacillus and the composite bacteria) are used as drug sensitive paper sheets, the culture is carried out for 48 hours at 28 ℃, the diameter of a bacteriostasis ring is measured, and the experimental result is shown in table 2. The results show that the antibacterial effect of the compound preparation of the invention on the lethal vibrio of acute hepatopancreatic necrosis syndrome of three south America white shrimps in Jiangsu is remarkably higher than that of vibrio phagostimuli, bacillus and lactobacillus (P)<0.01)。
TABLE 2 bacteriostatic activity of the strain on lethal strain of acute hepatopancreas necrosis syndrome of Penaeus vannamei Boone
Figure BDA0001746274900000041
Note: different letters indicate significant difference (P <0.05) and the same letters indicate insignificant difference (P > 0.05).

Claims (6)

1. The compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei boone is characterized by comprising the following components in parts by weight: the composite ecological preparation comprises Providencia sp and Enterobacter sp; wherein the preservation number of providencia is CGMCC No.15415, and the preservation number of enterobacter is CGMCC No. 15416.
2. The compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei according to claim 1, is characterized in that: the providencia and the enterobacteria are respectively cultured until the concentration is 1.0 multiplied by 108CFU/mL and mixing for later use.
3. The compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei according to claim 2, is characterized in that: the formula of the adopted culture medium is as follows: 5g of peptone, 1g of yeast extract, 0.01g of ferric phosphate, 3g of sodium acetate, 1g of dipotassium phosphate, 1000mL of old seawater and 7.6-7.8 of pH value.
4. The compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei according to claim 1, is characterized in that: the preparation ratio of the providencia and the enterobacter after liquid fermentation is 1: 0.5-2.
5. The compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei according to claim 1, is characterized in that: the providencia and the enterobacter account for 2-3% of the composite microecological preparation.
6. The application of the compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei according to claim 1, which is characterized in that: the compound microecological preparation is added into feed for feeding.
CN201810844204.1A 2018-07-27 2018-07-27 Compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei boone and application thereof Active CN109157546B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810844204.1A CN109157546B (en) 2018-07-27 2018-07-27 Compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei boone and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810844204.1A CN109157546B (en) 2018-07-27 2018-07-27 Compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei boone and application thereof

Publications (2)

Publication Number Publication Date
CN109157546A CN109157546A (en) 2019-01-08
CN109157546B true CN109157546B (en) 2021-05-28

Family

ID=64898527

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810844204.1A Active CN109157546B (en) 2018-07-27 2018-07-27 Compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei boone and application thereof

Country Status (1)

Country Link
CN (1) CN109157546B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112753629B (en) * 2020-12-30 2022-08-30 亚太海洋生物科技(厦门)有限公司 Method for removing acute hepatopancreas necrosis virus in early stage of culture of penaeus vannamei boone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003225946A1 (en) * 2002-03-21 2003-10-08 Board Of Regents, The University Of Texas System Methods and compositions for vaccination against or involvingenterobacteriaceae bacteria
CN103340277A (en) * 2013-06-07 2013-10-09 北京大北农科技集团股份有限公司 Feeding microecological additive and compound feed containing same
CN103966122B (en) * 2014-04-18 2016-05-11 中国科学院南海海洋研究所 One strain Providence and the application in preparation antibacterials thereof
CN104611251B (en) * 2014-12-09 2017-10-20 华南理工大学 One plant has the active lactic acid bacteria of broad-spectrum antibacterial and its application

Also Published As

Publication number Publication date
CN109157546A (en) 2019-01-08

Similar Documents

Publication Publication Date Title
Gullian et al. Selection of probiotic bacteria and study of their immunostimulatory effect in Penaeus vannamei
CN108251335B (en) Enterococcus faecalis HKF7 with lactic acid activity and screening culture method and application thereof
CN109749957B (en) Preparation and application of lactobacillus gasseri preparation with aquatic pathogenic bacteria antagonistic property
CN110734879A (en) Lactobacillus reuteri LR-CO21 and application thereof
CN111269865B (en) Brevibacillus laterosporus strain S62-9 and application thereof
CN107964524B (en) Lactococcus lactis HKS2 with lactic acid activity and separation and screening method and application thereof
CN104611251A (en) Lactic acid bacterium with wide-spectrum bacteriostatic activity and application thereof
Chau et al. Identification and characterization of Actinomycetes antagonistic to pathogenic Vibrio spp. isolated from shrimp culture pond sediments in Thua Thien Hue-Viet Nam
CN114933997B (en) Coral-derived symbiotic streptomyces SH001 and application thereof
CN114437964B (en) Bacillus belicus strain and application thereof
CN109157546B (en) Compound microecological preparation for preventing and controlling acute hepatopancreas necrosis syndrome of penaeus vannamei boone and application thereof
Orozova et al. Antibiotic resistance of potentially pathogenic Aeromonas strains
CN117143767B (en) Breast milk-derived fermented lactobacillus mucilaginosus MSJK capable of regulating intestinal flora and application thereof
CN112322553B (en) Clostridium difficile resistant lactococcus lactis and application thereof
WO2011132943A9 (en) Composition for treatment of acute pseudomembranous colitis
JP2010051247A (en) Biological control agent containing bacillus amyloliquefaciens having antibacterial activity against pathogenic bacterium and fungus as active ingredient
CN114854632B (en) Symbiotic salt spore fungus HZ014 derived from seaweed and application thereof
CN115216434B (en) Lactobacillus salivarius strain and application thereof
KR101201337B1 (en) A feed additive containig novel Lactobacillus spp. complex
Özkaya et al. Marine fungi against aquaculture pathogens and induction of the activity via co‐Culture
WO2022035082A1 (en) Lactic acid bacteria composition stable under strong acidic conditions
KR20100129505A (en) Use of exopolysaccharide derived from novel probiotic lactobacillus sp. for suppressing biofilm formation of phathogenic bacteria
CN111363723B (en) Novel vibrio cholerae bacteriophage and application thereof
Ebnetorab et al. Isolation, biochemical and molecular detection of Bacillus subtilis and Bacillus licheniformis from the digestive system of rainbow trout (Oncorhynchus mykiss) and its inhibitory effect on Aeromonas hydrophila
CN114806953A (en) Lactobacillus gasseri with characteristic of improving type 1 diabetes

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant